Publication:
Juvenile idiopathic inflammatory myopathy in a patient with dyskeratosis congenita due to C16orf57 mutation

Placeholder

Organizational Units

Authors

Kılıç, Sara Şebnem
Çekiç, Şükrü

Authors

Advisor

Language

Publisher:

Lippincott Williams & Wilkins

Journal Title

Journal ISSN

Volume Title

Abstract

Dyskeratosis congenita (DC) is a rare inherited disorder characterized by reticular skin pigmentation, oral cavity leukoplakia, and nail dystrophy. A variety of noncutaneous (dental, pulmonary, gastrointestinal, neurological, genitourinary, ophthalmic, and skeletal) abnormalities also have been reported. An 8-year-old boy with DC developed juvenile idiopathic inflammatory myopathy. C16orf57 mutation was identified as a genetic cause of DC. Treatment with methylprednisolone was initiated, followed with methotrexate, prednisolone, and high-dose intravenous immunoglobulin treatment. This is the first report on a patient with juvenile idiopathic inflammatory myopathy and DC.

Description

Source:

Keywords:

Keywords

Oncology, Hematology, Pediatrics, Dermatomyositis, Dyskeratosis congenital, Inflammatory myopathy, Immunodeficiency, C16orf57 mutation

Citation

Kılıç, S. Ş. ve Çekiç, Ş. (2016). "Juvenile idiopathic inflammatory myopathy in a patient with dyskeratosis congenita due to C16orf57 mutation". Journal of Pediatric Hematology/Oncology, 38(2), E75-E77.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads